iShares Healthcare Innovation UCITS ETF USD (Acc)'s (2B78:XETRA) last reported annual revenue was N/A.
iShares Healthcare Innovation UCITS ETF USD (Acc)'s (2B78:XETRA) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) is not profitable as of its last reported annual financials.
The net profit margin for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its laster reported year is N/A
The return on equity (ROE) for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its last reported annual financials is : N/A
The return on assets (ROA) for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its last reported annual financials is : N/A
The Debt to Equity ratio for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its last reported annual financials is : N/A
The dividend yield for iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) from its laster reported year is 0.60%
iShares Healthcare Innovation UCITS ETF USD (Acc)'s(2B78:XETRA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2B78:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
